Skip to content
HIV/AIDS
-
IMPALA Study finds two-monthly injectable HIV treatment safe and preferred by African patients
Results showed that the injectable regimen performed just as well as the daily oral dolutegravir-based therapy (TLD) but helped reduce the burden of daily medication.
-
Nigeria meets two of three global 95-95-95 HIV targets, moves closer to Ending AIDS by 2030
This progress was announced by Dr. Temitope Ilori, the Director-General of the National Agency for the Control of AIDS (NACA), during the World AIDS Day 2025 observance in Abuja.